Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review. | J Int Med Res | 2021 | 34057843 | PubTator, text mining | PubMed |
| Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M). | Patient | 2021 | 34056699 | PubTator, text mining | PubMed |
| The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML. | J Transl Med | 2021 | 34051812 | PubTator, text mining | PubMed |
| A protocol for rapid degradation of endogenous transcription factors in mammalian cells and identification of direct regulatory targets. | STAR Protoc | 2021 | 34041503 | PubTator, text mining | PubMed |
| Acute myeloid leukemia with T lymphoblastic lymphoma: a case report and literature review. | J Int Med Res | 2021 | 34038217 | PubTator, text mining | PubMed |
| Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies. | EClinicalMedicine | 2021 | 34036251 | PubTator, text mining | PubMed |
| Importance of Altered Gene Expression of Metalloproteinases 2, 9, and 16 in Acute Myeloid Leukemia: Preliminary Study. | J Oncol | 2021 | 34035811 | PubTator, text mining | PubMed |
| Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes. | Front Immunol | 2021 | 34025649 | PubTator, text mining | PubMed |
| RBM24 exacerbates bladder cancer progression by forming a Runx1t1/TCF4/miR-625-5p feedback loop. | Exp Mol Med | 2021 | 34021255 | PubTator, text mining | PubMed |
| Complex rearrangement in acute myeloid leukemia M2 with RUNX1/RUNX1T1 fusion involving chromosomes 8, 17 and 21. | Mol Cytogenet | 2021 | 34020686 | PubTator, text mining | PubMed |
| Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia. | Front Oncol | 2021 | 34017684 | PubTator, text mining | PubMed |
| Coexistence of BCR-ABL1 and RUNX1-RUNX1T1 in a de novo AML. | Blood | 2021 | 34014289 | PubTator, text mining | PubMed |
| Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How? | Front Immunol | 2021 | 34012445 | PubTator, text mining | PubMed |
| Anticancer Activity of Indeno[1,2-b]-Pyridinol Derivative as a New DNA Minor Groove Binding Catalytic Inhibitor of Topoisomerase IIα. | Biomol Ther (Seoul) | 2021 | 34011695 | PubTator, text mining | PubMed |
| Cytogenetic and mutational analysis and outcome assessment of a cohort of 284 children with de novo acute myeloid leukemia reveal complex karyotype as an adverse risk factor for inferior survival. | Mol Cytogenet | 2021 | 34011412 | PubTator, text mining | PubMed |
| Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter. | Blood | 2021 | 34010414 | PubTator, text mining | PubMed |
| PRICKLE1, a Wnt/PCP signaling component, is overexpressed and associated with inferior prognosis in acute myeloid leukemia. | J Transl Med | 2021 | 34001134 | PubTator, text mining | PubMed |
| Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia. | Transl Oncol | 2021 | 34000643 | PubTator, text mining | PubMed |
| Advances in therapeutic options for newly diagnosed, high-risk AML patients. | Ther Adv Hematol | 2021 | 33995985 | PubTator, text mining | PubMed |
| Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients. | Ann Hematol | 2021 | 33990890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=60